Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 25, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 27, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001951400-26-000004
Filed / recorded
Feb 27, 2026, 10:00 PM UTC
Added to OQRO
Oct 2, 2026, 3:52 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
AbbVie Inc.
Issuer CIK
1551152
Ticker
ABBV
Reporting person
Perry C Siatis
Relationship
Officer
Officer title
EVP, GC AND SECRETARY
Security
Option (Right to buy)
Table
Derivative (Table II)
Transaction date
Feb 25, 2026
Transaction code
M
Shares / units
7,775
Price per share
$175.28
Acquired / disposed
Disposed (D)
Shares owned after
7,774
Ownership form
Direct
Amendment
No
Footnotes from the filing
Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 7,775 on February 15, 2025 and 7,775 on February 15, 2026, and becomes exercisable as to 7,774 shares on February 15, 2027.